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Background. Healing of tibia fractures occurs over a wide time range of months, with a number of risk factors contributing
to prolonged healing. In this prospective, multicentre, observational study, we investigated the capability of FRACTING (tibia
FRACTure prediction healING days) score, calculated soon after tibia fracture treatment, to predict healing time. Methods. The
study included 363 patients. Information on patient health, fracture morphology, and surgical treatment adopted were combined
to calculate the FRACTING score. Fractures were considered healed when the patient was able to fully weight-bear without pain.
Results. 319 fractures (88%) healed within 12 months from treatment. Forty-four fractures healed after 12 months or underwent
a second surgery. FRACTING score positively correlated with days to healing: 𝑟 = 0.63 (𝑝 < 0.0001). Average score value was
7.3 ± 2.5; ROC analysis showed strong reliability of the score in separating patients healing before versus after 6 months: AUC
= 0.823. Conclusions. This study shows that the FRACTING score can be employed both to predict months needed for fracture
healing and to identify immediately after treatment patients at risk of prolonged healing. In patients with high score values, new
pharmacological and nonpharmacological treatments to enhance osteogenesis could be tested selectively, which may finally result
in reduced disability time and health cost savings.
1. Introduction
Over the past 50 years, orthopaedic surgery has defined, for
the different skeletal sites and different fracture morpholo-
gies, guidelines to ensure a suitable mechanical environment
to allow healing [1]. The treatment of tibia fractures has
become almost solely surgical, using nails, plates, and screws
and external fixation, to set the mechanical conditions (sta-
bility, contact, and alignment of the fracture fragments) for
bone repair [2–4]. Following surgical treatment, patients have
obtained significant benefits; limb function recovery is more
rapid, and joint stiffness or local osteoporosis is rare.
Bone healing results from the activity of different cell
populations at the fracture site [5, 6]; nowadays, orthopaedic
research aims to stimulate bone callus formation by pharma-
cological [7], cellular [8], and biophysical means [9] in order
to speed up fracture healing [10].
The tibia is the region with the highest incidence of
fractures resulting from trauma [3]. The healing of a tibia
fracture can occur over a very wide time range, from a
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minimum of 2 months to a maximum of 6 months in most
patients. Nevertheless, in a significant percentage of patients,
healing may take place well beyond 6 months after the
trauma or may require one or more surgical procedures, with
significant associated health costs [11–13].
Although general and local conditions that may adversely
affect fracture healing have been identified [14–18], the ability
to early recognise fractures at risk of developing a nonunion
is still left to the surgeon’s experience.
In a previous retrospective study, we assessed clinical
records of patients treated for tibia fractures to collect
information on trauma characteristics, fracture treatment,
patient’s general conditions, and finally the time required for
fracture healing. The data thus collected were analysed by
logistic regression to identify those parameters that influ-
enced time to fracture healing, and then they were combined
in a score whose values increased as time to healing increased
[19].
We conducted this prospective multicentre observational
study to (i) investigate, in a large cohort of patients, if
the score, calculated immediately after the treatment, could
reliably predict the time to healing of a tibia fracture and (ii)
determine the ability of the score to identify fractures at risk
of nonunion, that is, healing after more than 6 months.
2. Materials and Methods
This prospective observational study mirrors the clinical
practice for tibia fracture treatment throughout the country,
“real world data.” On this assumption, neither indication was
given on how to treat the fracture nor the review on treatment
appropriateness was performed.
From January 2010 to September 2012, patients who
had suffered a tibia fracture were recruited in 41 Italian
orthopaedic traumatology centres. Patient treatment was left
to the choice of the trauma surgeon based on experience. All
patients provided written, informed consent for the handling
of personal data. The study was approved by the ethical
committee of the coordinating centre: University of Ferrara,
Italy.
Inclusion criteria were as follows: patients with posttrau-
matic fractures type 41-A and B, 42-A-B and C, 43-A and B
according to AO classification [1]; fracture treatment within
3 days from trauma; and patient age > 18 years.
Exclusion criteria were as follows: fractures involving the
tibia plateau and malleolar fractures, patients with autoim-
mune diseases or neoplasia, and patients who could not
return to the treating centre for follow-up visits.
We selected a patient-centred end point to determine
fracture healing: fully weight-bearing without pain. Within
12 months from trauma, the date at which the fracture
healed was used to calculate days and months elapsed since
treatment (“healing time”). We chose to follow patient for 12
months after treatment as a small percentage of fracturesmay
slowly heal 6 months after the trauma [20–22].
Criteria for failure to heal included fractures not healed
within 12 months from trauma and fractures that required
surgical procedures not foreseen in the initial treatment plan.
2.1. Database. For each patient, surgical and clinical data
were collected in dedicated software and used to calculate
the score: FRACTING (FRACTure healING). Drop-down
menu was used for descriptive variables. Required fields
ensured complete and consistent data collection. The score
was calculated adding all values shown in Table 1.
As ancillary information, on the day of healing, surgeons
were asked to record on the database the presence of bone cal-
lus on tibia cortices in orthogonal radiographs; nevertheless
no centralised review of the X-rays was performed.
2.2. Statistical Analysis. We conducted a power analysis to
establish the number of patients required to demonstrate
the correlation of the score with time to healing with a
confidence interval of 0.10. Considering the correlation 𝑟 =
0.69 observed in the retrospective study, we calculated a
sample size of 301 patients.
In the descriptive analysis for continuous variables, mean
values and standard deviations are reported. ANOVAanalysis
with post hoc Bonferroni test has been applied for com-
parison between multiple groups. The association between
continuous variables was calculated by linear regression
analysis and Pearson linear correlation coefficient. In order to
determine the ability of the score to identify those who would
not heal within 6 months posttrauma, contingency tests
and receiver operating characteristic (ROC) analysis were
used; specificity, sensitivity and positive predictive values
were calculated. Data were analysed using SPSS 21.0 software
[IBM, New York, USA].
3. Results
3.1. Study Cohort. 519 patients were screened, 38 did not
meet the inclusion criteria, and 67 did not accept to be
enrolled. Finally, 414 patients with tibia fracture entered into
the database. Fifty-one patients (12%) did not return for
follow-up visits. Overall 363 patients completed the study
(Table 2) (Figure 1).
Twenty-one percent of fractures were open; in 3%, loss
of bone tissue occurred. In 75% of fractures, both tibia and
fibula were fractured. According to AO classification, 6% of
fractures were type 41, 72% were type 42, and 22% were type
43. Table 3 reports the treatment performed in open or closed
fractures.
Out of 363 patients, 319 (88%) healed within 12 months;
268 (74%) healed within 6 months and 51 (14%) between 6
and 12 months. Forty-four fractures (12%) were considered
failure as they required either further surgery or more than
12 months to heal. Figure 2 shows the percentage of fractures
healed at each month.
Fracture healing was achieved on average in 130 ± 54 days
for all patients.
At healing, the presence of callus was reported for 311
fractures: in at least three cortices in 81% of patients, in two
cortices in 15% of patients, and in one cortex only in 4% of
patients.
At long-term follow-up (6 months from healing), 93% of
fractures were reevaluated and their healing was confirmed;
4 BioMed Research International
Table 1: Parameters used for FRACTING score calculation.
Parameter Values for score calculation
Age increase
18–45 1
46–60 2
>60 3
Malnutrition Yes 1
Diabetes Yes 1
Smoking Yes 1
Use of NSAIDs Yes 1
Fracture exposure severity
Closed 1
Open grade 1 2
Open skin < 5 cm 3
Open skin > 5 cm 4
Location: metaphysis or epiphysis Yes 1
Synthesis device
Nail 1
Plate 2
External fixation 3
Unstable Yes 1
Misalignment > 5∘ Yes 1
Bone graft Yes 1
Plate + diastasis Yes 0.5
Angular stability plate Yes 0.5
Plate + plaster cast Yes −0.5
Fracture of tibia alone Yes 1
Loss of bone substance Yes 1
Bone diastasis, >2mm Yes 1
Length of surgery, >120 minutes Yes 1
Blood haemoglobin before treatment < 10 g/dl Yes 1
Blood haemoglobin after treatment < 10 g/dl Yes 1
NSAIDs: nonsteroidal anti-inflammatory drugs.
Table 2: Patients’ characteristics.
Male/female 257/106
Age (yrs) 48 ± 17
Weight (Kg) 74 ± 13
Height (cm) 171 ± 8
Table 3: Treatment performed in open or closed fractures.
No. of fractures treated Open Closed
External fixation 76 40 36
Nail 163 25 138
Plate & screws 124 12 112
Total 363 77 (21%) 286 (79%)
2 patients reported that the fracture, initially judged to be
healed, had over time been treated again.
3.2. Healing Time and FRACTING Score. The values of the
score ranged from 3 to 18, with a mean value of 7.3 ± 2.5,
median 7.
The correlation of the score with healing time expressed
in days is significant: 𝑟 = 0.63; 𝑝 < 0.0001 (Figure 3).
In traumatology practice, the patient follow-up interval
after treatment is usually 30 days. Therefore, we grouped the
fracture healing into five time intervals: ≤3, 4, 5, 6, and >6
months. The average score values by months after treatment
are reported in Table 4.
In further analysis we evaluated for different score values
the percentage of fractures healed at different time intervals
from trauma (Figure 4).
Among the 363 fractures, 12% of fractures with score
values ≤ 7 took more than 6 months to heal versus 43% of
fractures with score values > 7 (𝑝 < 0.0001). We performed
the ROC analysis to evaluate the ability of the score to predict
fracture healing in more than 6 months (nonunion); the area
under the curve (AUC) was 0.823 ± 0.033 (𝑝 < 0.0001). Data
for the sensitivity, specificity, and positive predictive value for
individual score values are shown in Table 5.
4. Discussion
To estimate healing time of a fracture immediately after
its treatment is difficult, it is based on individual surgeon’s
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519 screened patients
38 didn’t meet the
inclusions criteria
67 didn’t accept to be 
enrolled
414 included patients
51 lost to follow-up
363 evaluable patients
Figure 1: Flowdiagram inwhich the eligible, screened, and included
patients are illustrated.
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Figure 3: Linear correlation of the score value with fracture healing
time in days.
experience, and it is made even more difficult as to date there
is no accepted gold standard to determine the healing of
a fracture [23, 24]. Several clinical studies have considered
healing on both (i) radiographic criteria: presence of bone
callus in at least three cortices on radiographs performed
in the two projections, and (ii) clinical criteria: absence
of tenderness at the fracture site, the absence of pain on
application of pressure to the fracture site and during full
weight-bearing [21, 22, 25].
In this observational study, we tested the ability of the
FRACTING score to estimate immediately after fracture
treatment how long it will take to heal. Here, fracture healing
has been based exclusively on clinical criteria: full weight-
bearing without pain. This patient-centred end point is
relevant in clinical practice as it corresponds to the return
to work and daily activities. As confirmation of reliability of
the criteria for healing adopted, at 6-month follow-up, in 2
patients only, further treatment was required.
The FRACTING score is positively correlated with the
healing time in days (𝑟 = 0.63; 𝑝 < 0.0001). Furthermore,
ANOVA test shows a significant association among score
values and healing time in months (Table 4).
Within each score value (Figure 4), we observed fractures
healing at different time periods, thus leaving a range of
uncertainty that can be explained by individual biology,
patient’s behaviour, and adherence to the orthopaedic sur-
geon indications until healing. Nevertheless, it is noteworthy
that while for scores ≤5, 12% of fractures healed after 6
months from trauma, for scores >9, the percentage increased
to 61% (𝑝 < 0.0001).
The ROC analysis shows good reliability of the FRACT-
ING score to assess the risk of nonunion (AUC = 0.823). In
clinical practice, an effective thresholdmight be selected for a
score value of 8 that shows a sensitivity of 63%with specificity
of 81%, and a positive predictive value of 53% that shows that
the fracture heals in more than 6 months (Table 3).
To our knowledge this is the first attempt to prospectively
validate a score to predict fracture healing time.The results of
this study cannot be extended to skeletal segments other than
the tibia. However, our work suggests that the same approach
can be adopted to develop specific scores for fractures located
in different bones.
The major strength stems from the population studied
that represents real world data. FRACTING score is associ-
ated with fracture healing time and able to accurately identify
fractures at risk of nonunion.
Limitations include the exclusive use of clinical criteria
for definition of fracture healing, although only 2 patients
experienced fracture retreatment at follow-up.
5. Conclusions
FRACTING score might be used for selecting patients in
whom the efficacy of therapeutic interventions to enhance
fracture healing is assessed, such as cell therapy, growth
factors, drugs, or physical stimuli. Furthermore, patients with
high scoresmay benefit from customised treatment protocols
by planning closer surveillance and specific rehabilitation
6 BioMed Research International
Table 4: Average score values in different fracture healing months.
Healing months ≤3 4 5 6 >6
No. of fractures 74 81 69 44 51
Avg score (st.dev.) 4.97 (2.00) 6.33 (2.14) 6.86 (2.20) 7.42 (2.56) 8.71 (1.84)
ANOVA: 𝑝 < 0.0001
Post hoc analysis among scores: 𝑝 value
Healing months ≤3 4 5 6 >6
≤3 1
4 0.0379 1
5 0.0007 0.6341 1
6 0.0001 0.0401 0.5711 1
>6 0.0001 0.0001 0.0001 0.0038 1
Table 5: Sensitivity, specificity, and predictive value of the score to identify fracture healing in more than 6 months.
Score Sensitivity (%) Specificity (%) Positive predictive value (%)
3 100 5 27
4 98 12 28
5 94 28 31
6 94 50 38
7 80 65 43
8 63 81 53
9 53 90 65
10 43 97 82
11 20 100 94
12 16 100 100
Score = 6
(#64 fractures)
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Figure 4: Healing time of fractures grouped by score values.
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that might limit the occurrence of nonunions, thus leading
to significant cost savings [12, 13].
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